Dendrimers: A versatile targeting platform

Advanced Drug Delivery Reviews

Volumn 57, Issue 15, 2005, Pages 2104-2105

  Florence, Alexander T ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; DRUG CARRIER; GLUCOSAMINE 6 SULFATE; GLUCOSAMINE DERIVATIVE; UNCLASSIFIED DRUG; VIVAGEL;

BIOLOGY; EDITORIAL; GENE TARGETING; HUMAN; MEDICAL RESEARCH; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 28744439654     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.09.010     Document Type: Editorial

References (5)

1. J.S. Rutt Dendrimers and nanotechnology: a patent explosion, Foley and Larner Paper Presented at the National Nanotechnology Initiative Conference, Washington DC, April 29 2002 http://www.foley.com
2. N. Bourne, L.R. Stanbury, and E.R. Kern Dendrimers, a new class of candidate topical microbiocides with activity against herpes simplex virus infection Antimicrob. Agents Chemother. 44 2000 2471 2474
3. M. Witvrouw, V. Fikkert, and W. Pluymers Polyanionic (i.e. polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus (HIV) by interfering with both virus absorption and later steps (reverse transcriptase/integrase) in the virus replication cycle Mol. Pharmacol. 47 2000 1100 1108
4. S. Shaunak, S. Thomas, and E. Gianasi Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nat. Biotechnol. 22 2004 977 984
5. W.H. Hunt Nanomaterials: nomenclature, novelty and necessity JOM 56 2004 13